![KCI M8275058 300mL Canister (With Gel) For ActiV.A.C. Therapy System, Fluid Path Sterile (X) – GB TECH USA KCI M8275058 300mL Canister (With Gel) For ActiV.A.C. Therapy System, Fluid Path Sterile (X) – GB TECH USA](https://www.gbtechusa.com/wp-content/uploads/2021/11/IMG_0878-scaled.jpg)
KCI M8275058 300mL Canister (With Gel) For ActiV.A.C. Therapy System, Fluid Path Sterile (X) – GB TECH USA
![Cancers | Free Full-Text | Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study Cancers | Free Full-Text | Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study](https://pub.mdpi-res.com/cancers/cancers-13-01974/article_deploy/html/images/cancers-13-01974-ag-550.jpg?1618972040)
Cancers | Free Full-Text | Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA—A Proof of Concept Study
![mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis | Journal of Nuclear Medicine mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis | Journal of Nuclear Medicine](https://jnm.snmjournals.org/sites/default/files/highwire/jnumed/63/10.cover-source.jpg)